We have located links that may give you full text access.
Journal Article
Review
A Systematic Review of the Safety and Efficacy of Stenting of the Inferior Vena Cava.
European Journal of Vascular and Endovascular Surgery 2022 November 3
BACKGROUND: Stenting of the inferior vena cava (IVC) may provide benefit to patients with symptomatic obstruction, however there are no devices currently licensed for use in the IVC and systematic reviews on the topic are lacking.
METHODS: A systematic review of the literature was carried out according to PRISMA guidelines. The Medline and Embase databases were searched for studies reporting outcomes for safety and effectiveness of IVC stenting for any indication in series of 10 or more patients. The Newcastle Ottawa Score was used to assess risk of bias.
RESULTS: 33 studies were included describing 1,575 patients. Indications for stenting were malignant IVC syndrome (229 patients), thrombotic disease (807 patients), Budd-Chiari syndrome (501 patients) and IVC stenosis post liver transplantation (47 patients). The male: female ratio was 2:1 and the median age ranged from 30-61. The studies included were not suitable for formal metanalysis as 30/33 were single-centre retrospective studies with no control groups and there was considerable inconsistency in outcome reporting. There was significant risk of bias in 94% of studies. Median reported technical success was 100% (range 78-100%), primary patency was 75% (38-98%) and secondary patency was 91.5% (77-100%). Major complications were pulmonary embolism (3 cases), stent migration (12 cases) and major bleeding (15 cases) and 3 deaths in the immediate post-operative period. Most studies reported improvement in clinical symptoms but formal reporting tools were not used consistently.
CONCLUSION: The evidence base for IVC stenting consists of predominantly single-center, retrospective observational studies which have ahigh risk of bias. Nonetheless the procedure appears safe with few major adverse events, and studies that report clinical outcomes demonstrate improvement in symptoms and quality of life. Randomized controlled trials and prospective registry-based studies with larger patient numbers and standardized outcome are required to improve the evidence base for this procedure.
METHODS: A systematic review of the literature was carried out according to PRISMA guidelines. The Medline and Embase databases were searched for studies reporting outcomes for safety and effectiveness of IVC stenting for any indication in series of 10 or more patients. The Newcastle Ottawa Score was used to assess risk of bias.
RESULTS: 33 studies were included describing 1,575 patients. Indications for stenting were malignant IVC syndrome (229 patients), thrombotic disease (807 patients), Budd-Chiari syndrome (501 patients) and IVC stenosis post liver transplantation (47 patients). The male: female ratio was 2:1 and the median age ranged from 30-61. The studies included were not suitable for formal metanalysis as 30/33 were single-centre retrospective studies with no control groups and there was considerable inconsistency in outcome reporting. There was significant risk of bias in 94% of studies. Median reported technical success was 100% (range 78-100%), primary patency was 75% (38-98%) and secondary patency was 91.5% (77-100%). Major complications were pulmonary embolism (3 cases), stent migration (12 cases) and major bleeding (15 cases) and 3 deaths in the immediate post-operative period. Most studies reported improvement in clinical symptoms but formal reporting tools were not used consistently.
CONCLUSION: The evidence base for IVC stenting consists of predominantly single-center, retrospective observational studies which have ahigh risk of bias. Nonetheless the procedure appears safe with few major adverse events, and studies that report clinical outcomes demonstrate improvement in symptoms and quality of life. Randomized controlled trials and prospective registry-based studies with larger patient numbers and standardized outcome are required to improve the evidence base for this procedure.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app